John Cullen, Ph.D., J.D.
Dr. Cullen is an experienced senior executive and corporate attorney with thirty-five years experience in the pharmaceutical and related industries. He was most recently Senior Vice President & General Counsel at InKine Pharmaceutical Company, Inc., a specialty pharmaceutical company. Prior to 2005, Dr. Cullen was in private practice as an attorney and business consultant to the pharmaceutical and biotech industries. From 1994-96 he served as Chief Operating Officer for IBAH, Inc. (now Omnicare Clinical Services, Inc.), an international contract clinical research organization where he was responsible for worldwide operations. Prior to IBAH he held the position of Senior Vice President and Associate General Counsel for Business Operations at SmithKline Beecham Corporation (now, Glaxo SmithKline plc), where he was responsible for legal services to SmithKline Beecham’s North American pharmaceutical, consumer brands and veterinary divisions. Dr. Cullen has had substantial international, corporate, legal/regulatory and R&D experience in senior level negotiations with U.S. based and international corporate strategic partners, technical licensing and establishment of joint venture relationships. He earned his Ph.D. in Biochemistry from Seton Hall University and his law degree from Temple University. Dr. Cullen also completed a post-doctoral fellowship at Stanford and holds a B.S. in chemistry from Catholic University of America. He is a member of the Pennsylvania and American Bar Associations and is an adjunct Professor at Temple University where he teaches Food and Drug Law.